# Immune Mechanisms After Radiofrequency Ablation of Pulmonary Metastases From Colorectal Cancer Origin

> **NCT03960021** · NA · TERMINATED · sponsor: **Institut Bergonié** · enrollment: 20 (actual)

## Conditions studied

- Immune Evasion, Tumor
- Neoplastic Cells, Circulating
- Circulating Tumor Cell
- Pulmonary Metastasis
- Colo-rectal Cancer

## Interventions

- **RADIATION:** RFA interventions

## Key facts

- **NCT ID:** NCT03960021
- **Lead sponsor:** Institut Bergonié
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-03-04
- **Primary completion:** 2021-04-15
- **Final completion:** 2022-03-15
- **Target enrollment:** 20 (ACTUAL)
- **Why stopped:** Biological analyses could not be performed (technical reasons related to the machine). As such, it was not possible to assess primary/secondary outcomes.

No attempt will be made in the future to collect and/or report the data
- **Last updated:** 2026-03-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03960021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03960021, "Immune Mechanisms After Radiofrequency Ablation of Pulmonary Metastases From Colorectal Cancer Origin". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03960021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*